Skip to main content

Table 2 Follow-up schedule

From: Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial

  Before Treatment Years 3-5 Years 3-5
Every 3 months Month 3, 6, 12, 18 and 24 Every 6 months
History and Physical X X   X
Baseline staging investigations (see text) X    
CT head, chest, abdomen, pelvis    X X
Bone Scan    X X
Toxicity Scoring   X   X
FACT-G QOL scoring X X   X